Clinical Trials List
2022-04-01 - 2026-06-30
Phase II
Not yet recruiting2
Recruiting4
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
xxxxxx
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/11/13
Investigators and Locations
Co-Principal Investigator
- Yung-Chin Lee 無
- Hung-Lung Ke 無
- 黃俊農 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉詩彬 無
- Ying-Chun Shen 無
- - - 無
- CHUNG-HSIN CHEN 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
900 participants
